Authors
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Cancer Mortality Decreased Over 20 Years Despite COVID-19 PandemicFrom 2018 to 2022, cancer mortality dropped across race and ethnicity.
Latest:
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPCThe median overall survival with niraparib, abiraterone acetate, and prednisone was 30.4 months vs 28.6 months with abiraterone acetate and prednisone alone.
Latest:
Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology NurseMelanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.
Latest:
Many Patients Are Under-Sedated During End-of-Life Cancer CareDavid Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.
Latest:
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic CancerKaryn A. Goodman, MD, MS, provides perspective on the potential advantages of stereotactic body radiation therapy in locally advanced pancreatic cancer.
Latest:
A Multidisciplinary Approach Improves a Patient’s Experience With Colon CancerEarly coordination with multiple specialty teams can maximize outcomes and improve quality of life for patients with complex metastatic disease.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
FDA Declines Breakthrough Status, Halts Itolizumab’s Path Forward in Acute GVHDThe FDA’s decision not to grant breakthrough designation or accelerated approval for itolizumab in acute GVHD has led to the discontinuation of the pivotal phase 3 EQUATOR trial.
Latest:
Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell TherapySherry Adkins, MSN, ANP-C, discusses some key considerations in ensuring quality patient care after they have completed CAR T-cell therapy at a specialized center.
Latest:
Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCCKaty Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.
Latest:
Grace Choong and Matthew Goetz On the Impact of Adjuvant Endocrine Therapy Omission in ER+ Positive Breast CancerGrace Choong, MD; and Matthew Goetz, MD, discuss the effect of omitting adjuvant endocrine therapy for patients with estrogen receptor–positive breast cancer who were treated with neoadjuvant chemotherapy.
Latest:
Considerations for Premenopausal Women With TNBCTriple-negative breast cancer often occurs in women younger than 40.
Latest:
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient AmbulationSarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Latest:
Life After CAR T Therapy: Insights for Patients and Referring OncologistsThis video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.
Latest:
Brianna Lutz on How to Improve Nurse Responsiveness on an Inpatient Oncology UnitBrianna Lutz, MSN, RN, OCN, discusses a red-and-green dot hourly column that shows which patients with cancer have been attended to in the past hour.
Latest:
Kelley Rone on the Evolving Role of Immunotherapy in GI CancersKelley A. Rone, DNP, RN, AGNP-c, discusses the advantages associated with immunotherapy in the treatment of patients with gastrointestinal cancers.
Latest:
Nurse Role Is Key in Educating Patients on Benefit of Darolutamide Plus ADT in mHSPC“When discussing treatment options with patients, it is important to consider efficacy, safety, and the impact of treatment on patients’ quality of life [QOL]…,” noted Brenda Martone, RN, APP.
Latest:
Cancer Center gets $1.1M gift for holistic cancer careThe gift is from the estate of Tom and Catherine Culley, longtime residents of the East Coast and worldwide travelers.
Latest:
Reducing Health Inequities Among BIPOC Patients With MelanomaOne expert wrote that through education, prevention, and support, oncology nurses may play a role in reducing health inequities in melanoma.
Latest:
Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician InsightsExperts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.
Latest:
Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.
Latest:
Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast CancerCharles E. Geyer, MD, FACP, discusses dosing strategies and adverse event management with olaparib.
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
Opinion: Wilderness Therapy Offers Benefits to Patients With CancerWilderness therapy is a nontraditional form of therapy that uses components of exposure to outdoor activity and mental health treatment.
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Informing Patients on Integrative Oncology Can Enhance Supportive CareOncology nurses and APPs can enhance patients’ comfort by counseling patients on what integrative care is and working to make those options accessible.
Latest:
Setting Boundaries Can Be a Challenge for Nurse NavigatorsJanelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, highlights some challenges commonly associated with nurse navigation, and how nurses can overcome them.
Latest:
Kate Sandstrom on Ensuring Patient Follow-Up With Radiation Oncology TeamsKate Sandstrom, MSN, APRN-BC, AOCN, discusses the importance of including the radiation oncology team in a patient’s long-term care plan.
